Table 1 Demographic and clinical characteristics at time of liver transplantation, Johns Hopkins Hospital, 1996–2009
Characteristic | Frequency | |
|---|---|---|
n | (%) | |
Age (years) | ||
≤ 45 | 58 | (19.1) |
46–54 | 134 | (44.1) |
≥ 55 | 112 | (36.8) |
Mean age (±s.d.) | 51.5 | (±9.4) |
Gender (% male) | 199 | (65.5) |
Race | ||
White | 216 | (71.1) |
Black | 63 | (20.7) |
Other | 25 | (8.2) |
Cause of liver failure | ||
HCV | 142 | (46.9) |
HBV | 14 | (4.6) |
Alcohol | 30 | (9.9) |
Other | 117 | (38.6) |
MELD Era | ||
Pre-MELD era (before 2/2002) | 151 | (49.7) |
MELD era (after 2/2002) | 153 | (50.3) |
MELD score category | ||
< 10 | 11 | (3.7) |
10–19 | 166 | (55.3) |
20–29 | 85 | (28.3) |
30–39 | 32 | (10.7) |
≥ 40 | 6 | (2.0) |
Mean MELD Score (±s.d.) | 20.3 | (±7.6) |
eGFR Category at Tx | ||
≥ 90 | 138 | (46.0) |
60–89 | 66 | (22.0) |
30–59 | 65 | (21.7) |
< 30 | 31 | (10.3) |
Mean Pre-Tx eGFR-Epi (±s.d.) | 79.4 | (±34.5) |
Hepatorenal syndrome | 20 | (6.9) |
Hemodialyzed before OLT Transplantation | 8 | (2.8) |
Hemodialyzed after OLT | 13 | (4.5) |
Diabetes | 79 | (27.5) |
Hypertension | 55 | (19.4) |
Hepatitis C Virus | 139 | (48.1) |
Hepatocellular Carcinoma | 22 | (7.2) |
Mycophenolate Mofetil | 145 | (53.9) |
Steroids | 259 | (92.5) |
Allopurinol | 1 | (0.6) |
Calcineurin Inhibitor | ||
Tacrolimus | 204 | (67.1) |
Cyclosporine | 20 | (6.6 |
None | 8 | (2.6) |
Type not known | 72 | (23.7) |